Dr. Qi Jia, Ph.D., named President & CEO, Unigen, Inc.
Dr. Qi Jia, Ph.D., has been named President & CEO, Unigen, Inc., effective August 1, 2021. Dr. Jia has worked for the company 25 years since Unigen’s inception in 1996. The promotion to President & CEO is part of Unigen’s succession planning and positioning for its future and rapid growth. Dr. Jia succeeds Regan Miles, Unigen’s Vice Chairman.
Since joining Unigen as Director of Natural Products in 1996, Dr. Jia has established collaborations with multiple organizations around the world to collect indigenous medicinal plants and has built up a proprietary natural products library and the discovery platform, PhytoLogix®, with thousands of collections. He has lead product development and commercialization of nutritional and cosmetic ingredients with expanded responsibility as Vice President of Product Development between 1999 – 2004 and as Chief Scientific Officer from 2004 to present.
Dr. Jia holds 107 issued international patents and has 73 peer-reviewed publications and 64 oral or poster presentations at professional conferences in the field of natural products research. The ingredients Univestin® and Nivitol®, co-invented by Dr. Jia and Unigen scientists, have been utilized by global brands in joint health and even skin tone products.
Dr. Jia received his B.S. in Medicinal Chemistry from Beijing Medical University in 1985 and a Ph.D. in Organic Chemistry from Texas Christian University in 1995. Dr. Jia has studied ethnomedicinal plants for over 35 years. He has demonstrated a strong leadership and record of success in natural products discovery, development, commercialization and establishment of R&D collaborations with universities, institutes and industry partners.
As President and CEO, Dr. Jia will lead Unigen through the substantial growth trend forecasted for the biotech company and continue to fulfill its global vision of “Bringing the best of nature to humankind.”
Unigen discovers, develops and manufactures proprietary natural-product active ingredients for dietary supplements, cosmetic and personal care products, prescription medical food and botanical drug products. The Company discovers its ingredients through its high throughput screening PhytoLogix® approach applied to a proprietary well-annotated collection of botanicals and a legacy mining approach applied to botanicals having known medicinal benefits. Mechanism of action, safety and efficacy are documented with extensive preclinical in vitro and in vivo testing and by human clinical studies. Unigen protects its discoveries with issued patents and patent filings in all major territories and manufactures its products to GMP standards. Unigen commercializes its proprietary ingredients through licensing and ingredient supply alliances with commercial partners engaged in the manufacture, distribution and marketing of end-products in each of Unigen’s target markets. www.Unigen.net